Location History:
- London, GB (2020)
- Cambridge, GB (2022)
- Reading, GB (2015 - 2024)
Company Filing History:
8 out of 66 
6 out of 846 
2 out of 48 Years Active: 2015-2025
Title: Inventor Profile: Claire Williams from Reading, GB
Introduction
Claire Williams is an accomplished inventor based in Reading, GB, known for her significant contributions to the field of cannabinoid research. With a total of 11 patents to her name, her work primarily focuses on the therapeutic applications of cannabidiol (CBD) in various medical conditions, particularly those related to the central nervous system.
Latest Patents
Among her latest inventions, one notable patent describes the "Use of cannabidiol in the treatment of tuberous sclerosis complex". This invention highlights how CBD can decrease the number and size of marker cells associated with tumours in a zebrafish model of Tuberous Sclerosis Complex (TSC). The findings suggest that CBD may have a disease-modifying effect, potentially reducing or preventing benign tumours in patients suffering from TSC. The invention emphasizes the use of a highly purified cannabis extract, with over 98% CBD content and minimal levels of tetrahydrocannabinol (THC).
Another significant patent by Claire is a pharmaceutical composition that combines the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD). This composition is particularly effective in treating neurological conditions characterized by central nervous system hyper-excitability, seizures, or convulsions, such as epilepsy. The formulation is designed to ensure safety and efficacy while minimizing the presence of other cannabinoids, including THC.
Career Highlights
Claire Williams has had a notable career, working with reputable companies such as GW Pharmaceuticals and Otsuka Pharmaceutical Company, Limited. These experiences have enabled her to advance her research in cannabinoid therapies and have led to the development of her groundbreaking inventions.
Collaborations
Throughout her career, Claire has collaborated with esteemed colleagues, including Gary Stephens and Benjamin Whalley. Their combined expertise in the pharmaceutical field has contributed to her innovative approaches and successful patent filings.
Conclusion
Claire Williams is a prominent figure in cannabinoid research, with a portfolio of patents that emphasizes the therapeutic potential of CBD. Her work reflects a commitment to advancing medical treatments and improving patient outcomes, positioning her as an influential inventor in her domain.